Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial 

Similar presentations


Presentation on theme: "Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial "— Presentation transcript:

1 Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial  Prof Nikola Sprigg, FRCP, Katie Flaherty, MSc, Jason P Appleton, MRCP, Prof Rustam Al-Shahi Salman, FRCPEdin, Prof Daniel Bereczki, MD, Prof Maia Beridze, MD, Prof Hanne Christensen, DMSci, Alfonso Ciccone, MD, Ronan Collins, MD, Prof Anna Czlonkowska, MD, Robert A Dineen, FRCR, Prof Lelia Duley, FRCOG, Juan Jose Egea-Guerrero, MD, Timothy J England, FRCP, Kailash Krishnan, PhD, Ann Charlotte Laska, MD, Zhe Kang Law, MRCP, Prof Serefnur Ozturk, MD, Prof Stuart J Pocock, PhD, Prof Ian Roberts, FRCP, Prof Thompson G Robinson, FRCP, Prof Christine Roffe, FRCP, David Seiffge, MD, Polly Scutt, MSc, Jegan Thanabalan, MS, Prof David Werring, FRCP, Prof David Whynes, PhD, Prof Philip M Bath, FMedSci  The Lancet  DOI: /S (18)31033-X Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

2 Figure 1 Trial profile The Lancet DOI: (10.1016/S0140-6736(18)31033-X)
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

3 Figure 2 Shift plot of day 90 mRS
An mRS score of 0 represents no symptoms, 1 represents no disability despite symptoms, 2 represents slight disability but able to look after own affairs, 3 represents moderate disability but able to walk without assistance, 4 represents moderately severe disability (unable to walk or attend to own bodily needs), 5 represents severely disabled (bedridden and requiring constant nursing care), and 6 represents death. mRS=modified Rankin Scale. The Lancet DOI: ( /S (18)31033-X) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

4 Figure 3 Primary outcome by subgroups
All subgroups were predefined except for intracerebral haemorrhage volume, which was added as a post-hoc analysis. OR=odds ratio. NIHSS=National Institutes of Health Stroke Scale. The Lancet DOI: ( /S (18)31033-X) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions


Download ppt "Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial "

Similar presentations


Ads by Google